Generation of Biological Samples Positive to Triptorelin for Anti-doping Control

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

April 26, 2019

Primary Completion Date

May 15, 2019

Study Completion Date

May 15, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

Triptorelin

Subjects receive a single subcutaneous dose of 0,1 mg of Triptorelin acetate.

Trial Locations (1)

08003

IMIM (Hospital del Mar Medical Research Institute), Barcelona

All Listed Sponsors
lead

Parc de Salut Mar

OTHER